Yobe State: A Beacon of Hope in Nigeria's HIV/AIDS Fight
A Remarkable Journey to Low HIV Prevalence
In a heartening development, Yobe State has emerged as a leader in Nigeria's battle against HIV/AIDS, boasting an impressive 0.4% prevalence rate. This achievement is a testament to the state's unwavering commitment to innovative prevention strategies and life-saving treatments.
During the World HIV/AIDS Day commemoration in Damaturu, Dr. Jibril Damazai, Executive Secretary of Yobe State Agency for the Control of AIDS (YOSACA), revealed that 9,854 individuals living with HIV/AIDS are currently receiving treatment. He emphasized that the state's success is attributed to its aggressive approach, which has resulted in a remarkable 75% of those on treatment being healthy and non-infectious.
But here's where it gets controversial... Yobe aims to further reduce its prevalence rate to an astonishing 0.1% by 2035. To achieve this ambitious goal, the agency is intensifying its efforts, targeting a 0.25% prevalence rate by 2030. This involves extensive community outreach and technology-driven HIV testing, with the state government procuring an impressive 120 million test kits for house-to-house screening.
And this is the part most people miss... Yobe is leading the charge in Nigeria's transition to domestically funded prevention efforts, a crucial step given the estimated 80% reduction in global HIV funding. Governor Mai Mala Buni's support has been instrumental, with a 400% increase in YOSACA's funding and infrastructure upgrades.
Immunization: Protecting Children Against Preventable Diseases
In a related victory, Yobe's Primary Health Care Board (YPHCB) has immunized an impressive 1.4 million children against preventable diseases across all 17 local government areas. This achievement comes in response to reports of eight new polio cases in border communities near the Niger Republic.
Dr. Umar Chiroma, Director of Immunization and Disease Control, highlighted the success of the vaccination campaign, which ran from April to October 2025, targeting diseases like polio and cholera. He explained that three children contracted polio through contaminated water from dugout ponds, while two others were infected through contact with migrants from Diffa Province, Niger Republic.
Chiroma emphasized the challenges posed by cross-border migration and settlements along the Kumadugu/Yobe River, which hinder disease prevention efforts. Despite these obstacles, Yobe has made significant progress, vaccinating over 25,000 children in previously inaccessible areas like Tarmuwa, Jakusko, and the remote Tulwotulwo border community.
Dr. Uche Anunne shed light on the persistent challenges in immunization delivery, including infrastructure gaps, vaccine hesitancy, a limited healthcare workforce, and low literacy levels among caregivers. Communities like Nayinawa in Damaturu serve as a reminder of the work that still needs to be done.
Yobe's commitment to improving routine immunization is unwavering, with a target of raising coverage to 80% by 2026, in collaboration with UNICEF and other global health partners.
As we celebrate Yobe's achievements, it's important to acknowledge the ongoing challenges and the need for continued support and investment. What are your thoughts on Yobe's remarkable progress and the role of domestic funding in HIV/AIDS prevention? Share your insights and let's spark a conversation on this crucial topic!
